Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial

BACKGROUND: Thiazolidinedione ligands for the gamma subtype of peroxisome proliferator-activated receptors (PPARγ), widely used to treat type 2 diabetes mellitus, have been proposed as novel therapies for ulcerative colitis. METHODS: This multicenter randomized, double blind, placebo-controlled clin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lewis, James D., Lichtenstein, Gary R., Deren, Julius J, Sands, Bruce E., Hanauer, Stephen B., Katz, Jeffry A., Lashner, Bret, Present, Daniel H., Chuai, Shaokun, Ellenberg, Jonas H., Nessel, Lisa, Wu, Gary D.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2007
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2276587/
https://ncbi.nlm.nih.gov/pubmed/18325386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2007.12.012
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia